WESPAC Advisors’s Geron GERN Stock Holding History

WESPAC Advisors’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-108,640	Closed	-$263K	–	116
2022 Q4	$263K	Buy	108,640 +19,000	+21%	+$42.6K	0.46%	51
2022 Q3	$210K	Buy	+89,640	New	+$201K	0.28%	76

Other funds holding GERN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

WESPAC Advisors's GERN Position: Q1 2023 in Review

WESPAC Advisors sold out of Geron (GERN) in Q1 2023, closing a stake of 108,640 shares — an estimated $263K sold.

WESPAC Advisors first reported a position in GERN in Q3 2022 and held it in 2 quarters. The position peaked at $263K in Q4 2022. 191 funds tracked by Wall St. Rank hold GERN as of Q1 2023.

WESPAC Advisors reported no remaining Geron position as of Q1 2023 after selling out during the quarter.
WESPAC Advisors sold 108,640 Geron shares in Q1 2023, an estimated $263K.
WESPAC Advisors first reported a position in Geron in Q3 2022 and held it in 2 quarters.
WESPAC Advisors's Geron position peaked at $263K in Q4 2022.
191 funds tracked by Wall St. Rank held Geron as of Q1 2023.

Based on WESPAC Advisors's 13F filing for Q1 2023, filed 27 Apr 2023.